GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 355 filers reported holding GLOBUS MED INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,267,385 | -21.5% | 609,615 | -5.9% | 0.49% | -11.3% |
| Q2 2023 | $38,560,783 | +5.1% | 647,645 | 0.0% | 0.55% | +3.4% |
| Q1 2023 | $36,682,613 | -27.4% | 647,645 | -4.8% | 0.53% | -20.6% |
| Q4 2022 | $50,516,969 | +31.0% | 680,180 | +5.1% | 0.67% | +21.2% |
| Q3 2022 | $38,551,000 | +4.6% | 647,163 | -1.4% | 0.55% | +6.1% |
| Q2 2022 | $36,866,000 | -33.0% | 656,681 | -11.9% | 0.52% | -18.3% |
| Q1 2022 | $54,985,000 | +0.5% | 745,254 | -1.6% | 0.64% | +13.1% |
| Q4 2021 | $54,689,000 | -2.1% | 757,464 | +3.8% | 0.56% | -0.5% |
| Q3 2021 | $55,888,000 | -1.2% | 729,420 | 0.0% | 0.57% | +2.7% |
| Q2 2021 | $56,552,000 | +41.6% | 729,420 | +12.7% | 0.55% | +30.8% |
| Q1 2021 | $39,932,000 | +4.7% | 647,509 | +10.8% | 0.42% | -3.4% |
| Q4 2020 | $38,128,000 | +87.9% | 584,612 | +42.7% | 0.44% | +56.1% |
| Q3 2020 | $20,290,000 | +22.3% | 409,735 | +17.8% | 0.28% | +19.1% |
| Q2 2020 | $16,590,000 | +15.4% | 347,729 | +2.9% | 0.24% | -15.8% |
| Q1 2020 | $14,378,000 | -27.7% | 338,067 | +0.1% | 0.28% | -11.4% |
| Q4 2019 | $19,892,000 | +30.7% | 337,837 | +13.5% | 0.32% | +11.3% |
| Q3 2019 | $15,217,000 | +31.5% | 297,666 | +8.8% | 0.28% | +42.9% |
| Q2 2019 | $11,568,000 | -1.8% | 273,482 | +14.7% | 0.20% | -69.4% |
| Q1 2019 | $11,785,000 | +77.9% | 238,510 | +55.9% | 0.65% | +49.0% |
| Q4 2018 | $6,623,000 | -22.9% | 153,031 | +1.2% | 0.44% | -20.2% |
| Q3 2018 | $8,585,000 | +129.8% | 151,251 | +104.3% | 0.54% | +70.8% |
| Q2 2018 | $3,736,000 | +53.5% | 74,045 | +51.6% | 0.32% | +32.4% |
| Q1 2018 | $2,434,000 | +21.2% | 48,850 | 0.0% | 0.24% | +14.8% |
| Q4 2017 | $2,008,000 | +22.8% | 48,850 | -11.2% | 0.21% | +22.8% |
| Q3 2017 | $1,635,000 | +23.3% | 55,000 | +37.5% | 0.17% | +8.9% |
| Q2 2017 | $1,326,000 | +11.9% | 40,000 | 0.0% | 0.16% | -0.6% |
| Q1 2017 | $1,185,000 | -45.5% | 40,000 | -54.4% | 0.16% | -64.6% |
| Q4 2016 | $2,176,000 | +10.0% | 87,700 | 0.0% | 0.45% | +24.6% |
| Q3 2016 | $1,979,000 | -5.3% | 87,700 | 0.0% | 0.36% | -8.9% |
| Q2 2016 | $2,090,000 | +0.3% | 87,700 | 0.0% | 0.39% | +4.0% |
| Q1 2016 | $2,083,000 | – | 87,700 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |